Brief: Neogenomics Receives Medicare Coverage For Radar St For Immunotherapy Treatment Response Monitoring
26/08/2026 21:29
BRIEF-Neogenomics Receives Medicare Coverage For Radar St For Immunotherapy Treatment Response Monitoring Aug 26 (Reuters) - NeoGenomics, Inc. NEO.O:
NEOGENOMICS RECEIVES MEDICARE COVERAGE FOR RADAR ST FOR IMMUNOTHERAPY TREATMENT RESPONSE MONITORING
Source text: ID:nBw7FzK6da
Further company coverage: NEO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeoGenomics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
NeoGenomics rises after BTIG upgrades to 'buy'
Brief: Neogenomics Announces Executive Leadership And Board Of Directors Succession Plan
Brief: Neogenomics Receives Medicare Coverage For Radar St For Immunotherapy Treatment Response Monitoring